Deepak Chadha - 18 May 2021 Form 4 Insider Report for Brickell Biotech, Inc.

Role: Chief Research & Dev. Officer
Signature: /s/ Christine G. Long, Attorney-in-Fact for Chadha Deepak (power of attorney previously filed)
Issuer symbol: N/A
Transactions as of: 18 May 2021
Net transactions value: +$12,589
Form type: 4
Filing time: 19 May 2021, 17:01:49 UTC
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FRTX	Common Stock	Purchase	$2,212	+2,700	+4.3%	$0.8191	65,667	18 May 2021	Direct
transaction	FRTX	Common Stock	Purchase	$10,378	+12,500	+19%	$0.8302	78,167	19 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the purchase of 12,500 shares in multiple transactions, ranging in price from $0.814 to $0.857 per share, resulting in a weighted average purchase price of $0.8302. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.